BeneFIX® RT

Control and Prevention of Bleeding Episodes in Hemophilia B

BeneFIX®, Coagulation Factor IX (Recombinant), is indicated for the control and prevention of bleeding episodes in adult and pediatric patients with hemophilia B (congenital factor IX deficiency or Christmas disease).

Peri-operative Management in Patients with Hemophilia B

BeneFIX®, Coagulation Factor IX (Recombinant), is indicated for peri-operative management in adult and pediatric patients with hemophilia B.

BeneFIX®, Coagulation Factor IX (Recombinant), is NOT indicated for:

a. treatment of other factor deficiencies (e.g., factors II, VII, VIII, and X),

b. treatment of hemophilia A patients with inhibitors to factor VIII,

c. reversal of coumarin-induced anticoagulation,

d. treatment of bleeding due to low levels of liver-dependent coagulation factors.

For indications, dosing and other information, please refer to the prescribing information.

BeneFIX® RT ‐ Pfizer

Size:
250 unit vial
NDC #:
58394-0633-03
Download:
PI
Size:
500 unit vial
NDC #:
58394-0634-03
Download:
PI
Size:
1000 unit vial
NDC #:
58394-0635-03
Download:
PI
Size:
2000 unit vial
NDC #:
58394-0636-03
Download:
PI
Size:
3000 unit vial
NDC #:
58394-0637-03
Download:
PI